Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 14

1.

The impact of hormone replacement therapy on quality of life and willingness to pay.

Zethraeus N, Johannesson M, Henriksson P, Strand RT.

Br J Obstet Gynaecol. 1997 Oct;104(10):1191-5.

PMID:
9332999
[PubMed - indexed for MEDLINE]
2.

Hormone replacement therapy: I. A pharmacoeconomic appraisal of its therapeutic use in menopausal symptoms and urogenital estrogen deficiency.

Whittington R, Faulds D.

Pharmacoeconomics. 1994 May;5(5):419-45. Review. Erratum in: Pharmacoeconomics 1995 Sep;8(3):244.

PMID:
10147233
[PubMed - indexed for MEDLINE]
3.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

PMID:
17999840
[PubMed - indexed for MEDLINE]
Free Article
4.

Undertreatment of menopausal symptoms and novel options for comprehensive management.

Lewis V.

Curr Med Res Opin. 2009 Nov;25(11):2689-98. doi: 10.1185/03007990903240519. Review.

PMID:
19775194
[PubMed - indexed for MEDLINE]
5.

Literature review of instruments to assess health-related quality of life during and after menopause.

Zöllner YF, Acquadro C, Schaefer M.

Qual Life Res. 2005 Mar;14(2):309-27. Review.

PMID:
15892422
[PubMed - indexed for MEDLINE]
6.

Hormone replacement therapy: II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease.

Whittington R, Faulds D.

Pharmacoeconomics. 1994 Jun;5(6):513-54. Review.

PMID:
10147266
[PubMed - indexed for MEDLINE]
7.

[Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].

Gaspard U, van den Brûle F, Pintiaux A, Foidart JM.

Rev Med Liege. 2002 Aug;57(8):556-62. Review. French.

PMID:
12405030
[PubMed - indexed for MEDLINE]
8.

Prognostic features of menopausal and postmenopausal applicants for life insurance.

Schiefeling M.

J Insur Med. 1996;28(1):27-34. Review.

PMID:
10172866
[PubMed - indexed for MEDLINE]
9.

Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.

Baber R, Hickey M, Kwik M.

Drug Saf. 2005;28(12):1085-100. Review.

PMID:
16329712
[PubMed - indexed for MEDLINE]
10.

Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy.

Pearce J, Hawton K, Blake F.

Br J Psychiatry. 1995 Aug;167(2):163-73. Review.

PMID:
7582665
[PubMed - indexed for MEDLINE]
11.

Menopause, hormone therapy, and quality of life.

Utian WH.

Prog Clin Biol Res. 1989;320:193-209. Review. No abstract available.

PMID:
2690136
[PubMed - indexed for MEDLINE]
12.

[Menopausal hormone replacement therapy and prevention of neurologic complications].

Lopes P, Mensier A, Laurent FX, Besse O.

Contracept Fertil Sex. 1995 May;23(5):319-22. Review. French.

PMID:
7613577
[PubMed - indexed for MEDLINE]
13.

Menopause and schizophrenia.

Gupta R, Assalman I, Bottlender R.

Menopause Int. 2012 Mar;18(1):10-4. doi: 10.1258/mi.2012.011116. Epub 2012 Feb 3. Review.

PMID:
22308532
[PubMed - indexed for MEDLINE]
14.

Safety of post-menopausal hormone replacement.

Critchley HO, Farrell EA, Healy DL.

Aust N Z J Med. 1992 Apr;22(2):103-5. Review. No abstract available.

PMID:
1530529
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk